Vial Adaptors for Reconstitution Drug Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Vial Adaptors for Reconstitution Drug Market is Segmented by Material Type (Polycarbonate, Silicon, Polyethylene, and Others), Therapeutic Area (Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Vial Adaptors for Reconstitution Drugs Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Vial Adaptors For Reconstitution Drug Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 7.30 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Vial Adaptors For Reconstitution Drug Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Vial Adaptors for Reconstitution Drugs Market Analysis

The Vial Adaptors for Reconstitution Drug Market is poised to witness a CAGR of 7.3% during the forecast period.

The market was affected by the COVID-19 pandemic. During the initial phase, the lockdown and away from other drugs adversely impacted the market. However, with the approval of the vaccine, the market started to grow. For instance, in November 2022, an article published in the National Library of Medicine stated that the choice of the vaccine packaging type, either a single- or multi-dose vial, is a crucial determinant of vaccine coverage. Due to this, the adoption of vial adaptors is expected to increase, which is expected to increase market growth over the forecast period.

The major factor contributing to the growth of the market is the increasing prevalence and incidence of chronic diseases and infectious diseases. According to the study published in the National Center for Biotechnology Information updated in August 2021, 19.5% of patients in ICU had at least one Hospital Acquired Infection. These infections can be acquired from other patients, hospital staff, or the hospital textiles such as curtains. Similarly, the Sexually Transmitted Infections Treatment Guidelines, 2021, published by the Centers for Disease Control and Prevention, stated that genital herpes is a chronic, lifelong viral infection. Two types of HSV can cause genital herpes: HSV-1 and HSV-2. Most cases of recurrent genital herpes are caused by HSV-2, and 11.9% of persons aged 14-49 years are estimated to be infected in the United States (436). Thus, the increasing prevalence of infectious diseases is expected to increase the consumption of drugs, which is expected to increase market growth over the forecast period.

Furthermore, the growing awareness about the advantages of using vial adaptors is the major factor boosting the market growth. For instance, in September 2021, an article published in the National Library of Medicine stated that chemotherapy drug wasting is a huge problem in oncology that not only results in excessive expenses on chemotherapy drugs but also increases the cost of disposing of chemotherapy waste and the risk of occupational exposure in the environment. However, employing a real-time vial-sharing strategy using an intelligent robot to dispense multiple prescriptions simultaneously is cost-effective. Additionally, this approach presented no safety issue concerns, such as the introduction of impurities to sterile compounding via repeated interspersing or the incorrect registration of information during drug storage, often encountered with traditional vial-sharing strategies. Thus, such research studies are expected to increase market growth over the forecasting period.

However, the availability of substitutes is a major drawback of market growth.

Vial Adaptors for Reconstitution Drugs Market Trends

Infectious Diseases Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi; the diseases can be spread, directly or indirectly, from one person to another.

According to a survey conducted by WHO for the period from 24 January 2022 to 06 February 2022, approximately 12,368 were positive for influenza viruses. Thus, with the high prevalence of the different types of influenza globally, more technologically advanced products are required, which may drive the market studied during the forecast period. Similarly, as per the October 2022 update of the World Health Organization, the incidence of tuberculosis (TB) was estimated to be around 10.6 million people in 2021 globally, of which 1.2 million were children.

The ongoing research, development, and company initiatives in the development and launch of advanced therapeutics involving biopharmaceuticals, along with government initiatives regarding the prevention and management of inflammatory and infectious diseases, are also expected to have a significant impact on the growth of the studied market as these factors will not only increase the availability of products in the market but also increase the awareness among people regarding the effectiveness of biopharmaceuticals. This is expected to increase the consumption of such products, which is expected to increase the demand for vials, and hence, the market is anticipated to grow. For instance, in June 2022, the Clinical Development Services Agency (CDSA) of India launched the Indian Council of Medical Research (ICMR) tuberculosis (TB) vaccine trial for healthy household contact with TB patients. In the trial, two potential vaccines were shortlisted for an ICMR-led Phase III trial of 12000 healthy household contacts of sputum smear-positive TB patients. CDSA has provided study start-up support to all sites and oversaw the recruitment and vaccination of the first participant at the National Institute of Tuberculosis and Respiratory Diseases (NITRD), New Delhi. Thus, such clinical trials are expected to increase segment growth over the forecast period.

Thus, considering the rising prevalence of infectious diseases and clinical trials, the market is expected to grow over the forecast period.

Vial Adaptors For Reconstitution Drug Market: Estimated Number of Influenzas Cases, by Type, Global, January 2022 - February 2022

North America is Expected to Hold a Significant Market Share Over the Forecast Period

North America is expected to dominate the overall vial adaptors for reconstitution drug market throughout the forecast period. The market growth is due to factors such as the presence of key players, established healthcare infrastructure, and availability of branded drugs, which are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. The Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021-2025 (Viral Hepatitis Plan), released on January 7, 2021, provides a framework to eliminate viral hepatitis as a public health threat in the United States by 2030. The Viral Hepatitis Plan focuses on hepatitis A, hepatitis B, and hepatitis C-the three most common hepatitis viruses that have the most impact on the health of the nation. The same source is estimated to reduce new hepatitis A virus infections from 4,000 in 2023 to 2,500 in 2028; Hepatitis B virus infections from 18,000 in 2023 to 2,200 in 2028; and Hepatitis C virus infections from 35,000 in 2023 to 4,400 in 2028. Furthermore, growing investments for better-analyzing disease models will drive the market. For instance, in April 2021, the government of Canada launched five multidisciplinary infectious disease modeling networks, with a total investment of USD 10 million, to strengthen ties between the academic community, industry, and the public sector. The results will significantly improve the coordination of infectious disease modeling to help Canada better respond to future public health threats, which will lead the market to grow.

Vial Adaptors for Reconstitution Drug Market - Growth Rate by Region

Vial Adaptors for Reconstitution Drugs Industry Overview

The vial adaptors for reconstitution drug market is moderately competitive and consist of several major players. Some of the market players include Miltenyi Biotec, Baxter, Randox Laboratories Ltd, West Pharmaceutical Services Inc., B. Braun Medical Inc., Shimadzu Corporation, and Thermo Fisher Scientific.

Vial Adaptors for Reconstitution Drugs Market Leaders

  1. Miltenyi Biotec

  2. Randox Laboratories Ltd

  3. Sartorious AG

  4. West Pharmaceutical Services, Inc.

  5. Baxter International Inc.

*Disclaimer: Major Players sorted in no particular order

Vial Adaptors For Reconstitution Drug Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Vial Adaptors for Reconstitution Drugs Market News

  • Dec 2022: The life science group Sartorius and Sweden-based BICO Group, a provider of instruments and consumables for bioprinting, bioscience, and automation applications, agreed on a comprehensive technology as well as sales and marketing cooperation.
  • Dec 2021: Miltenyi Biotec BV & Co. KG expanded its presence with a new production plant in Teterow, Germany.

Vial Adaptors for Reconstitution Drugs Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Infectious Diseases

      2. 4.2.2 Rising Geriatric Population

      3. 4.2.3 Increasing Awareness of the Advantages of the Vial Adaptors

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Substitutes

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Material

      1. 5.1.1 Polycarbonate

      2. 5.1.2 Silicon

      3. 5.1.3 Polyethylene

      4. 5.1.4 Other Materials

    2. 5.2 By Therapeutic Area

      1. 5.2.1 Autoimmune Diseases

      2. 5.2.2 Infectious Diseases

      3. 5.2.3 Metabolic Conditions

      4. 5.2.4 Other Therapeutic Areas

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies

      2. 6.1.2 ARaymond

      3. 6.1.3 B. Braun SE

      4. 6.1.4 Baxter International Inc.

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Miltenyi Biotec

      7. 6.1.7 Randox Laboratories Ltd

      8. 6.1.8 Sartorious AG

      9. 6.1.9 Simplivia

      10. 6.1.10 Stevanato Group

      11. 6.1.11 Thermo Fisher Scientific

      12. 6.1.12 West Pharmaceutical Services Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Vial Adaptors for Reconstitution Drugs Industry Segmentation

As per the scope of the report, vial adapters are a cost-effective solution for the safe and rapid transfer and reconstitution of drugs between vials and syringes. Adaptors enable the optimal aspiration of mixed and reconstituted drugs. 

The Vial Adaptors for Reconstitution Drug Market is Segmented by Material Type (Polycarbonate, Silicon, Polyethylene, and Other Material Types), Therapeutic Area (Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, and Other Therapeutic Areas), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Material
Polycarbonate
Silicon
Polyethylene
Other Materials
By Therapeutic Area
Autoimmune Diseases
Infectious Diseases
Metabolic Conditions
Other Therapeutic Areas
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Vial Adaptors for Reconstitution Drugs Market Research FAQs

The Vial Adaptors for Reconstitution Drug Market is projected to register a CAGR of 7.30% during the forecast period (2024-2029)

Miltenyi Biotec, Randox Laboratories Ltd, Sartorious AG, West Pharmaceutical Services, Inc. and Baxter International Inc. are the major companies operating in the Vial Adaptors for Reconstitution Drug Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Vial Adaptors for Reconstitution Drug Market.

The report covers the Vial Adaptors for Reconstitution Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vial Adaptors for Reconstitution Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Vial Adaptors for Reconstitution Drug Industry Report

Statistics for the 2024 Vial Adaptors for Reconstitution Drug market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vial Adaptors for Reconstitution Drug analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Vial Adaptors for Reconstitution Drug Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)